Cargando…

Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients

BACKGROUND: There is a lack of standardisation in quality of life (QoL) measurements to be used in older multimorbid patients. An ideal QoL measurement should be reliable, valid, subjective, multidimensional, feasible and generic. We hypothesised that the QoL-AD (Quality of Life in Alzheimer’s Disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Torisson, Gustav, Stavenow, Lars, Minthon, Lennart, Londos, Elisabet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908755/
https://www.ncbi.nlm.nih.gov/pubmed/27301257
http://dx.doi.org/10.1186/s12955-016-0493-8
_version_ 1782437739412586496
author Torisson, Gustav
Stavenow, Lars
Minthon, Lennart
Londos, Elisabet
author_facet Torisson, Gustav
Stavenow, Lars
Minthon, Lennart
Londos, Elisabet
author_sort Torisson, Gustav
collection PubMed
description BACKGROUND: There is a lack of standardisation in quality of life (QoL) measurements to be used in older multimorbid patients. An ideal QoL measurement should be reliable, valid, subjective, multidimensional, feasible and generic. We hypothesised that the QoL-AD (Quality of Life in Alzheimer’s Disease) scale could have these properties. Our aim was to determine the psychometric properties and clinical correlations of QoL-AD in a population of elderly, multimorbid medical inpatients. METHODS: QoL-AD was performed in 200 medical inpatients, and available caregivers. Reliability was determined using cronbach’s alpha and corrected item-total correlations. The agreement between patient and proxy ratings were examined using intra-class correlations (ICC). Correlations between QoL-AD and demographic data, comorbidity, cognitive tests, ADL (activities of daily living) and depression were examined. To characterise the underlying constructs of QoL-AD, an exploratory factor analysis was performed. RESULTS: In total, 199 patients fulfilled the QoL-AD rating, with 139 proxy ratings. Cronbach’s alpha (95 % CI) was 0.74 (0.68–0.79) for patients and 0.86 (0.83–0.90) for proxies. Patient-proxy ICC (95 % CI) was 0.31 (0.16–0.46). Lower QoL was correlated to depression, cognitive impairment, ADL impairment and solitary living, but not with comorbidity. The factor analysis gave a three-factor solution, with factors representing phsyical, social and psychological well-being. CONCLUSION: The QoL-AD scale showed some promising properties but more research is needed before it can be recommended in this setting. If replicated, the finding that cognitive impairment, depression and ADL impairment were more associated with lower QoL than somatic comorbidity could have clinical implications for further studies aiming to improve QoL in this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0493-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4908755
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49087552016-06-16 Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients Torisson, Gustav Stavenow, Lars Minthon, Lennart Londos, Elisabet Health Qual Life Outcomes Research BACKGROUND: There is a lack of standardisation in quality of life (QoL) measurements to be used in older multimorbid patients. An ideal QoL measurement should be reliable, valid, subjective, multidimensional, feasible and generic. We hypothesised that the QoL-AD (Quality of Life in Alzheimer’s Disease) scale could have these properties. Our aim was to determine the psychometric properties and clinical correlations of QoL-AD in a population of elderly, multimorbid medical inpatients. METHODS: QoL-AD was performed in 200 medical inpatients, and available caregivers. Reliability was determined using cronbach’s alpha and corrected item-total correlations. The agreement between patient and proxy ratings were examined using intra-class correlations (ICC). Correlations between QoL-AD and demographic data, comorbidity, cognitive tests, ADL (activities of daily living) and depression were examined. To characterise the underlying constructs of QoL-AD, an exploratory factor analysis was performed. RESULTS: In total, 199 patients fulfilled the QoL-AD rating, with 139 proxy ratings. Cronbach’s alpha (95 % CI) was 0.74 (0.68–0.79) for patients and 0.86 (0.83–0.90) for proxies. Patient-proxy ICC (95 % CI) was 0.31 (0.16–0.46). Lower QoL was correlated to depression, cognitive impairment, ADL impairment and solitary living, but not with comorbidity. The factor analysis gave a three-factor solution, with factors representing phsyical, social and psychological well-being. CONCLUSION: The QoL-AD scale showed some promising properties but more research is needed before it can be recommended in this setting. If replicated, the finding that cognitive impairment, depression and ADL impairment were more associated with lower QoL than somatic comorbidity could have clinical implications for further studies aiming to improve QoL in this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0493-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-14 /pmc/articles/PMC4908755/ /pubmed/27301257 http://dx.doi.org/10.1186/s12955-016-0493-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Torisson, Gustav
Stavenow, Lars
Minthon, Lennart
Londos, Elisabet
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
title Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
title_full Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
title_fullStr Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
title_full_unstemmed Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
title_short Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
title_sort reliability, validity and clinical correlates of the quality of life in alzheimer’s disease (qol-ad) scale in medical inpatients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908755/
https://www.ncbi.nlm.nih.gov/pubmed/27301257
http://dx.doi.org/10.1186/s12955-016-0493-8
work_keys_str_mv AT torissongustav reliabilityvalidityandclinicalcorrelatesofthequalityoflifeinalzheimersdiseaseqoladscaleinmedicalinpatients
AT stavenowlars reliabilityvalidityandclinicalcorrelatesofthequalityoflifeinalzheimersdiseaseqoladscaleinmedicalinpatients
AT minthonlennart reliabilityvalidityandclinicalcorrelatesofthequalityoflifeinalzheimersdiseaseqoladscaleinmedicalinpatients
AT londoselisabet reliabilityvalidityandclinicalcorrelatesofthequalityoflifeinalzheimersdiseaseqoladscaleinmedicalinpatients